Immunotherapy cocktail aims to turn untreatable stomach tumors into surgical targets
Disease control
Not yet recruiting
This phase 2 trial tests whether combining two immunotherapy drugs (ipilimumab and sintilimab) with chemotherapy (modified XELOX) can shrink locally advanced stomach cancer that cannot be surgically removed. The goal is to make the tumors small enough for surgery. The study enrol…
Phase: PHASE2 • Sponsor: Chen Lizhu • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC